CAS: 1189481-51-3
Formula:C34H29D4N3O5
InChI:InChI=1S/C34H33N3O5/c1-40-28-9-5-7-26-32(28)36-31-25(33(26)38)6-4-8-27(31)34(39)35-24-12-10-21(11-13-24)14-16-37-17-15-22-18-29(41-2)30(42-3)19-23(22)20-37/h4-13,18-19H,14-17,20H2,1-3H3,(H,35,39)(H,36,38)/i14D2,16D2
InChI key:InChIKey=OSFCMRGOZNQUSW-RCYYZLFTSA-N
SMILES:O=C(NC1=CC=C(C=C1)CCN2CC3=CC(OC)=C(OC)C=C3CC2)C4=CC=CC=5C(=O)C=6C=CC=C(OC)C6NC45
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Elacridar-d4 (Major) REF: TR-E489002CAS: 1189481-51-3 | - - - | 261.00 €~1,753.00 € | Tue 21 May 24 |
 | Elacridar-d4 REF: 3D-PXB48151CAS: 1189481-51-3 | Min. 95% | To inquire | Thu 20 Jun 24 |
Elacridar-d4 (Major)
Controlled ProductCAS:1189481-51-3
Applications A prototypical BCRP inhibitor. Inhibits the Bcrp1-mediated transport. References Neville, K., et al.: Clin. …
Formula:
C34H29D4N3O5
Color and Shape:
Light Yellow To Yellow
Molecular weight:
567.67
Ref: TR-E489002
| 1mg | 261.00 € | |
| 10mg | 1,753.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
Elacridar-d4
CAS:1189481-51-3
Please enquire for more information about Elacridar-d4 including the price, delivery time and more detailed …
Formula:
C34H33N3O5
Purity:
Min. 95%
Molecular weight:
567.7 g/mol
Ref: 3D-PXB48151
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 20 Jun 2024
